| Structure | Chemical Name | CAS | MF |
|
MORPHOLINO[3-(2-THIENYL)-6-(TRIFLUOROMETHYL)THIENO[3,2-B]PYRIDIN-2-YL]METHANONE
|
|
C17H13F3N2O2S2
|
|
Morpholine, 2,6-dimethyl-4-[(3-methyl-2-benzofuranyl)carbonyl]- (9CI)
|
588674-74-2
|
C16H19NO3
|
|
MORPHOLINE STEARATE
|
|
C22H45NO3
|
|
2-Morpholinecarboxamide,N-methyl-(9CI)
|
135072-21-8
|
C6H12N2O2
|
|
2,5-Morpholinedione, 4-acetyl-6-methyl-, (S)- (9CI)
|
114712-07-1
|
C7H9NO4
|
|
MORPHINE SULFATE NARCOTIC ANALGESIC
|
64-31-3
|
C18H25NO8S
|
|
MORPHINE MONOHYDRATE CII (50 MG) (AS)
|
6009-81-0
|
C17H21NO4
|
|
2-(4-MORPHOLINO)ETHYLAZID
|
|
C6H12N4O
|
|
1-(2-MORPHOLIN-4-YL-ETHYL)-1H-PYRROLE-2-CARBALDEHYDE
|
383135-71-5
|
C11H16N2O2
|
|
MORPHINE,SHEEPANTI-
|
|
|
|
|
2-Morpholin-4-Pyrimidine Carboxaldehyde
|
|
|
|
Morpholine, 4-(4-isocyanophenyl)- (9CI)
|
356533-73-8
|
C11H12N2O
|
|
(2-MORPHOLIN-4-YL-1H-BENZIMIDAZOL-1-YL)ACETIC ACID
|
|
C13H15N3O3
|
|
2-(MORPHOLIN-4-YLCARBONYL)-8-PHENYL-1,6-NAPHTHYRIDINE
|
|
C19H17N3O2
|
|
8-(MORPHOLIN-4-YL)-5-NITROQUINOLINE
|
304884-33-1
|
C13H13N3O3
|
|
3-MORPHOLINOBENZOIC ACID
|
215309-00-5
|
C11H13NO3
|
|
2-(MORPHOLIN-4-YLMETHYL)-1H-BENZIMIDAZOLE
|
|
C12H15N3O
|
|
(3-MORPHOLINOPHENYL)METHANOL
|
145127-38-4
|
C11H15NO2
|
|
Morpholine, 4-(1-iminoethyl)- (9CI)
|
153558-51-1
|
C6H12N2O
|
|
6-MORPHOLIN-4-YL-4-O-TOLYL-NICOTINAMIDE
|
|
C17H19N3O2
|
|
(2-MORPHOLIN-4-YLETHYL)(PHENYLSULFONYL)AMINE
|
|
C12H18N2O3S
|
|
6-MORPHOLINONICOTINOYL CHLORIDE
|
313350-36-6
|
C10H11ClN2O2
|
|
|
4-MORPHOLINE-3-NITROBENZALDEHYDE, 95%+.
|
|
|
|
2-Morpholinone,5-methyl-4-propyl-,(5S)-(9CI)
|
710654-85-6
|
C8H15NO2
|
|
4-morpholinopiperidine-4-carboxamide
|
53654-12-9
|
C10H19N3O2
|
|
6-([4-(MORPHOLIN-4-YLCARBONYL)-1,4-DIAZEPAN-1-YL]CARBONYL)-3,4-DIHYDRONAPHTHALEN-1(2H)-ONE
|
|
C21H27N3O4
|
|
4-MORPHOLIN-4-YL-3-NITRO-BENZOIC ACID
|
|
C11H12N2O5
|
|
|
MORPHINE(SPECIFIC),NORMORPHINE(44.4%),SHEEPANTI-
|
|
|
|
|
MORPHOGENETICPROTEIN-2,MOUSEANTI-HUMANBONE
|
|
|
|
MORPHOLINE, ISOPROPYL-
|
1331-24-4
|
|
|
1-[3-MORPHOLINO-4-(2-PYRIDINYL)-1H-PYRAZOL-1-YL]-1-ETHANONE
|
|
C14H16N4O2
|
|
|
4-Morpholinecarboxamide,N-2-propynyl-(9CI)
|
643083-75-4
|
C8H12N2O2
|
|
2-[3-(MORPHOLINE-4-SULFONYL)-PHENYL]-2,3-DIHYDRO-ISOINDOL-1-YLIDENEAMINE
|
|
C18H19N3O3S
|
|
2-Morpholinone,5-methyl-3-(1-methylethyl)-,(3S,5R)-(9CI)
|
277302-75-7
|
C8H15NO2
|
|
(2-MORPHOLIN-4-YL-4-PHENYL-1,3-THIAZOL-5-YL)METHANOL
|
|
C14H16N2O2S
|
|
Morpholine, 4-[(2R)-oxiranylmethyl]- (9CI)
|
452105-35-0
|
C7H13NO2
|
|
[3-(4-MORPHOLINYLMETHYL)-5-ISOXAZOLYL]METHANAMINE
|
|
C9H15N3O2
|
|
2-[3-(4-MORPHOLINYLMETHYL)-1,2,4-OXADIAZOL-5-YL]ETHYLAMINE
|
|
C9H16N4O2
|
|
Morpholine, 2-(4-fluorophenyl)-3,5-dimethyl-, [2S-(2alpha,3ba,5ba)]- (9CI)
|
785019-72-9
|
C12H16FNO
|
|
4-MORPHOLINO-5H-PYRIMIDO[5,4-B]INDOLE
|
|
C14H14N4O
|
|
4-[2-(4-MORPHOLINYL)ETHOXY]-3-(TRIFLUOROMETHYL)-PHENYLAMINE
|
|
C13H17F3N2O2
|
|
Morpholine, 2-(1-piperazinylmethyl)- (9CI)
|
122894-75-1
|
C9H19N3O
|
|
|
2-Morpholinol,4-ethyl-(9CI)
|
141477-97-6
|
C6H13NO2
|
|
Morpholine, 2,2,6,6-tetrafluoro- (9CI)
|
65502-95-6
|
C4H5F4NO
|
|
Morpholine, 4-nitro- (6CI, 7CI, 8CI, 9CI)
|
4164-32-3
|
C4H8N2O3
|
|
4-Morpholinamine,3,5-dimethyl-,cis-(9CI)
|
152813-38-2
|
C6H14N2O
|
|
4-Morpholineethanimidoyl chloride, N-hydroxy-alpha-oxo- (9CI)
|
83656-61-5
|
C6H9ClN2O3
|
|
|
3-(1-MORPHOLINO)PROPYL-FUNCTIONALIZED SILICA GEL
|
|
|
|
4-(4-MORPHOLINYLMETHYL)PHENYLBORONIC ACID
|
|
C11H16BNO3
|
|
4-(3-morpholinylmethyl)-2,5-xylenol hydrochloride
|
61791-78-4
|
C13H20ClNO2
|
|
5-(2-MORPHOLIN-4-YL-ETHYLAMINO)-NAPHTHALENE-1-SULFONIC ACID
|
|
C16H20N2O4S
|
|
1-MORPHOLIN-4-YLMETHYL-PROPYLAMINE
|
847798-58-7
|
C8H18N2O
|
|
|
1-MORPHOLINOCARBONITRILE(1-CYANOMORPHOLINE)
|
|
|
|
2-(4-Morpholin-4-yl-phenyl)-benzothiazole
|
95856-76-1
|
C17H16N2OS
|
|
5-MORPHOLIN-4-YLMETHYL-3-[(2-NITRO-BENZYLIDENE)-AMINO]-OXAZOLIDIN-2-ONE-D5
|
|
C15H13D5N4O5
|
|
5-(MORPHOLINE-4-SULFONYL)-2-PIPERIDIN-1-YL-BENZOIC ACID
|
554437-00-2
|
C16H22N2O5S
|
|
|
5-MORPHOLINOMETHYL-3-(5-NITROFURFURYLIDENEAMINO)OXAZOLIDON.
|
|
|
|
3-MORPHOLIN-4-YL-1-NAPHTHALEN-1-YL-3-PHENYL-PROPENONE
|
|
C23H21NO2
|
|
MORPHOLINE-4-CARBOXIMIDOHYDRAZIDE HYDROIODIDE
|
|
C5H13IN4O
|
|
2-MORPHOLINOBENZOIC ACID
|
42106-48-9
|
C11H13NO3
|
|
3-MORPHOLINO-4-(2-PYRIDINYL)-N-[3-(TRIFLUOROMETHYL)PHENYL]-1H-PYRAZOLE-1-CARBOXAMIDE
|
|
C20H18F3N5O2
|
|
1-(MORPHOLINOMETHYL)-1H-INDOLE-2,3-DIONE 3-(N-PHENYLHYDRAZONE)
|
|
C19H20N4O2
|
|
3-MORPHOLINECARBOXYLIC ACID METHYL ESTER
|
126264-49-1
|
C6H11NO3
|
|
4-(4-MORPHOLINO)-3-NITROBENZALDEHYDE
|
300541-91-7
|
C11H12N2O4
|
|
|
2-Morpholinone,3-ethoxy-5,5-dimethyl-4-(1-methylethyl)-(9CI)
|
136476-61-4
|
C11H21NO3
|
|
4-(MORPHOLINE-4-SULPHONYL)-BENZENESULPHONYL CHLORIDE
|
|
C10H12ClNO5S2
|
|
4-Morpholinobenzaldehyde
|
1204-86-0
|
C11H13NO2
|
|
Morpholine, 4-(4-pyrimidinyl)- (9CI)
|
706748-29-0
|
C8H11N3O
|
|
4'-(4-MORPHOLINYL)[1,1'-BIPHENYL]-2-CARBALDEHYDE
|
|
C17H17NO2
|
|
Morpholine,4-(ethoxyacetyl)-
|
600139-83-1
|
C8H15NO3
|
|
3-MORPHOLIN-4-YL-PROPIONALDEHYDE
|
19851-01-5
|
C7H13NO2
|
|
|
MORPHLINE BENZOATE
|
|
|
|
Morpholine, 4-(4-ethoxy-1,2,5-thiadiazol-3-yl)- (9CI)
|
329227-79-4
|
C8H13N3O2S
|
|
MORPHOLINO(5-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)PYRIDIN-3-YL)METHANONE
|
1073371-92-2
|
C16H23BN2O4
|
|
2-MORPHOLINO-THIOPHENE
|
19983-19-8
|
C8H11NOS
|
|
Morpholine, 4-[[[4-(3,5-dimethyl-1H-pyrazol-1-yl)-1-phthalazinyl]thio]acetyl]- (9CI)
|
606122-18-3
|
C19H21N5O2S
|
|
MORPHINE-3,6-DIGLUCURONIDE TETRAHYDRATE, DEA SCHEDULE II
|
64947-41-7
|
C29H35NO15.4H2O
|
|
MORPHOLIN-4-YL-(4-TRIFLUOROMETHYL-PHENYL)-ACETIC ACID HYDROCHLORIDE
|
|
C13H15ClF3NO3
|
|
MORPHOLINO[3-(1H-PYRROL-1-YL)-2-THIENYL]METHANONE
|
|
C13H14N2O2S
|
|
4-Morpholinobutyronitrile
|
5807-11-4
|
C18H14N2O
|
|
2-(MORPHOLIN-4-YL)-3-AMINOQUINOXALINE
|
480439-23-4
|
C12H14N4O
|
|
4'-MORPHOLINOMETHYL-3-TRIFLUOROMETHYLBENZOPHENONE
|
898770-38-2
|
C19H18F3NO2
|
|
|
1-[4-(2-Morpholin-4-yl-ethoxy)-phenyl]-propan-1-
|
|
|
|
3-MORPHOLIN-4-YL-PROPIONIC ACID HCL
|
6319-95-5
|
C7H14ClNO3
|
|
4-[(MORPHOLINOAMINO)METHYLENE]-5-PHENYL-2,4-DIHYDRO-3H-PYRAZOL-3-ONE
|
|
C14H16N4O2
|
|
MORPHOLIN-4-YL-PIPERIDIN-4-YL-METHANONE
|
|
C10H18N2O2
|
|
|
MORPHOGENETICPROTEIN-2,HUMANPROBONE,RECOMBINANT
|
|
|
|
morpholinium salicylate
|
147-90-0
|
C11H15NO4
|
|
6-(4-(3-[5-(MORPHOLIN-4-YLCARBONYL)PYRIDIN-3-YL]PROPYL)PIPERAZIN-1-YL)-1H-PURINE
|
|
C22H28N8O2
|
|
MORPHOLINOFORMAMIDINE HYDROBROMIDE
|
74618-32-9
|
C5H12BrN3O
|
|
|
4-Morpholinepropionohydroxamicacid,2,6-dimethyl-(8CI)
|
802893-74-9
|
C9H18N2O3
|
|
Morpholine, 4-(dichloroacetyl)-2,6-dimethyl- (9CI)
|
349106-93-0
|
C8H13Cl2NO2
|
|
2-(4-MORPHOLINYL)-16-(1-PYRROLIDINYL)-ANDROSTANE-3,17-DIOL 17-ACETATE
|
|
C29H48N2O4
|
|
|
4-(4-MORPHOLINO)-3-NITROBENZALDEHYDE 94%
|
|
|
|
|
MORPHOLINOMETHYL POLYSTYRENE (100-200 MESH, CA. 4.0 MMOL/G)
|
|
|
|
|
MORPHINESULPHATEPENTAHYDRATE
|
|
|
|
(4-MORPHOLIN-4-YLMETHYL-PHENOXY)-ACETIC ACID
|
|
C13H17NO4
|
|
2-MORPHOLIN-4-YLMETHYLBENZOIC ACID
|
868543-19-5
|
C12H15NO3
|
|
4-(4-MORPHOLIN-4-YL-PHENYLCARBAMOYL)-BUTYRIC ACID
|
|
C15H20N2O4
|
|
4'-(MORPHOLIN-4-YLSULFONYL)-1,1'-BIPHENYL-4-AMINE
|
|
C16H18N2O3S
|